A novel drug could be used to treat neglected tropical diseases developed by researchers which can prompt genuine inability and affect more than 157 million individuals globally. University of Liverpool – UK, to deliver the first novel completely manufactured and soundly structured anti-Wolbachia drug, AWZ1066S, could potentially be used to cure onchocerciasis and lymphatic filariasis (LF). Onchocerciasis are caused by the filarial worm transmitted by repeated bites of infected blackflies and LF occurs when filarial parasites are transmitted to humans through mosquitoes. Steve Ward, researcher at University of Liverpool said,…
Read MoreCategory: News
FDA approves Artificial Intelligence Software for Identifying Brain Bleeds
According to a recent report, Food and Drug Administration (FDA) has given approval for the software developed by MaxQ AI. The software is an Artificial Intelligence-based solution to diagnose and determine non-contrast CT examination images which is known as brain bleeds. Accipio Ix Intracranial Hemorrhage (ICH) of MaxQ AI uses the artificial intelligence technology platform to analyze head CT images automatically. Aidoc says that it is first of its kind in-depth learning solution to benefit radiologists in workflow group. Without affecting the workflow of the physician, this Healthcare AI technology…
Read More4th Annual Infection Control, Sterilization and Decontamination Congress Announced with Speaker Line-up of Leading NHS Hospitals
MarketsandMarkets presents to you the 4th Annual Infection Control, Sterilization & Decontamination in Healthcare Congress to be held on 28th February – 1st March 2019, in London, UK. The 2-day event will host more than 30 expert speakers, 10+ sponsors, 150+ professionals working in Hospitals, Research Institutes and Universities. This 2-day, 2-stream congress will primarily focus on three aspects of hospital associated infections – Infection control, Decontamination and Sterilization. The expected attendance of 150+ delegates will include leading expert professionals from NHS & Private Hospitals, Research Institutes and Universities across…
Read MoreFDA to Update Premarket Guidance for Medical Device Security
FDA Commissioner Scott Gottlieb, on 5th September said, “FDA is planning to update its premarket guidance for medical device security.” He further added, “We have made significant progress to improve the cybersecurity of medical devices. But the industry is rapidly evolving with respect to data security and we need to keep up the pace.” This guidance will have recommendations for manufacturers for the protection against moderate and major ricks which are capable of disrupting & exploiting clinical operations through remote attack. He further added that the FDA will share number…
Read More